In the US, Hycamtin (topotecan systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Cancer, Cervical Cancer, Ovarian Cancer and Small Cell Lung Cancer.
US matches:
- Hycamtin
- Hycamtin Capsules
- Hycamtin Intravenous
UK matches:
- Hycamtin 0.25mg and 1 mg hard capsule (SPC)
- Hycamtin 1mg and 4mg powder for concentrate for solution for infusion (SPC)
Ingredient matches for Hycamtin
Topotecan
Topotecan is reported as an ingredient of Hycamtin in the following countries:
Topotecan hydrochloride (a derivative of Topotecan) is reported as an ingredient of Hycamtin in the following countries:
- Argentina
- Australia
- Austria
- Bahrain
- Belgium
- Brazil
- Canada
- Chile
- China
- Croatia (Hrvatska)
- Czech Republic
- Denmark
- Finland
- France
- Germany
- Greece
- Hong Kong
- Hungary
- Iceland
- Iran
- Israel
- Italy
- Japan
- Kuwait
- Luxembourg
- Netherlands
- Norway
- Oman
- Poland
- Portugal
- Qatar
- Romania
- Russian Federation
- Singapore
- Slovakia
- Slovenia
- South Africa
- Spain
- Sweden
- Switzerland
- Thailand
- Turkey
- United Arab Emirates
- United Kingdom
- United States
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and
International Nonproprietary Names.